课题基金 / 基金详情

Genetic Analysis of African American Hypertensive End-Stage Renal Disease

Genetic Analysis of African American Hypertensive End-Stage Renal Disease
非裔美国人高血压终末期肾病的基因分析
批准号:
7226754
负责人:
BARRY Ira FREEDMAN
金额:
$39.88万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2010-04-30

项目摘要

项目成果

BARRY Ira FREEDMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by investigator): The focus of this application is to locate and identify one or more genes that cause hypertension-associated end-stage renal (H-ESRD) disease in the African American population. Hypertensive end-stage renal disease is one of the leading causes of kidney failure in the United States and it disproportionately affects African Americans. This application builds upon a genome scan in 264 African American families containing index cases with H-ESRD and their siblings with end-stage kidney failure. We will perform fine mapping of the regions with the strongest evidence of linkage in the genome scan analysis. Linkage support intervals defined by the fine mapping process will be prioritized based on the evidence for linkage in our sample and other published data. High priority regions will be surveyed for candidate genes that could contribute to hypertension and H-ESRD. These genes will be subjected to a focused high density single nucleotide polymorphism (SNP) mapping effort, block identification and tested for association (e.g., single locus and haplotype) under a case-control design. The case-control sample is independent of the genome scan sample. The signal locus and haplotype analyses should help identify individual polymorphisms and haplotypes that are in linkage disequilibrium with H-ESRD. We anticipate that an intensive genetic analysis for the identification of haplotype blocks will facilitate the search for polymorphisms. Mapping the genes that predispose to hypertensive kidney disease will provide a framework for identifying the pathways that initiate or promote renal failure and could ultimately lead to the development of novel medications to prevent or slow progression of hypertensive kidney failure in African Americans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUBCLINICAL CVD IN AFRICAN AMERICAN TYPE 2 DIABETICS
GENETICS OF AFRICAN AMERICAN TYPE 2 DIABETES HIGH BLOOD PRESSURE
Natural History of MYH9-Associated Nephropathy
SUBCLINICAL CVD IN AFRICAN AMERICAN TYPE 2 DIABETICS
国内基金
海外基金
染色体9p21.3区域遗传变异与体细胞突变在食管鳞癌发生中的作用及其生物学机制研究
  • 批准号:
    81572421
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    高勇
  • 依托单位:
5p15.33、7p11.2、8q24.21、9p21.3、11q23.3和20q13.33座位遗传多态与胶质母细胞瘤放疗后生存的关系研究
  • 批准号:
    81372417
  • 项目类别:
    面上项目
  • 资助金额:
    16.0万元
  • 批准年份:
    2013
  • 负责人:
    陈怡东
  • 依托单位: